Announced
Completed
Synopsis
Equity investment in Merus, a Netherlands-based developer of bispecific antibody therapeutics, by Incyte.
Principals
Show Details & Financials
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.